Winthrop Partners - WNY’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,729
Closed -$1.22M 88
2025
Q4
$1.22M Buy
+12,729
New +$1.24M 0.66% 40
2019
Q3
$751K Buy
6,918
+1,090
+19% +$114K 0.51% 58
2019
Q2
$568K Buy
5,828
+5,728
+5,728% +$523K 0.43% 61
2019
Q1
$9.07K Hold
100
0.01% 197
2018
Q4
$9.1K Hold
100
0.01% 204
2018
Q3
$9.84K Hold
100
0.01% 239
2018
Q2
$8.56K Hold
100
0.01% 261
2018
Q1
$7.85K Buy
+100
New +$8.25K 0.01% 355

Other funds holding MDT

Winthrop Partners - WNY's MDT Position: Q1 2026 in Review

Winthrop Partners - WNY sold out of Medtronic (MDT) in Q1 2026, closing a stake of 12,729 shares — an estimated $1.22M sold.

Winthrop Partners - WNY first reported a position in MDT in Q1 2018 and held it in 8 quarters. The position peaked at $1.22M in Q4 2025. 2,244 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Winthrop Partners - WNY reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Winthrop Partners - WNY sold 12,729 Medtronic shares in Q1 2026, an estimated $1.22M.
  • Winthrop Partners - WNY first reported a position in Medtronic in Q1 2018 and held it in 8 quarters.
  • Winthrop Partners - WNY's Medtronic position peaked at $1.22M in Q4 2025.
  • 2,244 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Winthrop Partners - WNY's 13F filing for Q1 2026, filed 7 May 2026.